IMNM Message Board Post 18155666 | Immunome Inc.
home / stock / imnm / imnm message board
Jesseclark
(investorshub)
Posted on: Jun/29/2023 13:42:46
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172237795
Ha, sold in fall of 21 for $25.
News, Short Squeeze, Breakout and More Instantly...
-
Immunome , Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the appointment of Phil Tsai, PhD, as Chief Technical Officer. Dr. Tsai has nearly three decades of experience in product development, proces...
-
2024-05-21 22:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the completion of its purchase of antibodies and related assets from Atreca, Inc. Under the terms of the agreement, Immunome paid Atreca $5.5 mi...